Effect of COVID-19 pandemic on psoriatic patients dermatology admissions and biologic treatment adherences: A single-center retrospective study.
作者信息
Özdemir Ahmet Kağan, Hayran Yıldız, Şen Orhan, Aktaş Akın
机构信息
Department of Dermatology, Ankara City Hospital, Ankara, Turkey.
出版信息
J Cosmet Dermatol. 2021 Nov;20(11):3362-3363. doi: 10.1111/jocd.14512. Epub 2021 Oct 11.
Abstract
摘要
相似文献
1
Effect of COVID-19 pandemic on psoriatic patients dermatology admissions and biologic treatment adherences: A single-center retrospective study.2019年冠状病毒病大流行对银屑病患者皮肤科住院及生物治疗依从性的影响：一项单中心回顾性研究。
J Cosmet Dermatol. 2021 Nov;20(11):3362-3363. doi: 10.1111/jocd.14512. Epub 2021 Oct 11.
2
Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto.多伦多大学两所学术医院诊所中COVID-19大流行期间患者驱动的生物治疗停药率。
J Cutan Med Surg. 2020 Jul/Aug;24(4):424-425. doi: 10.1177/1203475420930226. Epub 2020 Jun 1.
3
Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.COVID-19 大流行期间生物治疗的银屑病患者监测：单中心经验。
Dermatol Ther. 2021 Jan;34(1):e14700. doi: 10.1111/dth.14700. Epub 2020 Dec 28.
4
Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.初步数据表明，皮肤科使用的生物制剂与新冠肺炎不良结局无关。
J Cutan Med Surg. 2020 Jul/Aug;24(4):420-421. doi: 10.1177/1203475420929250. Epub 2020 May 25.
5
Continuation and Discontinuation Rates of Biologics in Dermatology Patients During COVID-19 Pandemic.COVID-19大流行期间皮肤科患者生物制剂的持续使用和停用率
J Cutan Med Surg. 2021 Nov-Dec;25(6):646-647. doi: 10.1177/12034754211024125. Epub 2021 Jun 9.
6
Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?冠状病毒（COVID-19）大流行是否意味着需要暂时修改皮肤病管理计划？
J Drugs Dermatol. 2020 Apr 1;19(4):436.
7
Organization of biologic therapy during the COVID-19 pandemic based on example of Dermatology Clinic Centre of Postgraduate Medical Education in Warsaw.基于华沙医学继续教育研究生院皮肤科诊所的例子，组织 COVID-19 大流行期间的生物治疗。
J Dermatolog Treat. 2022 Mar;33(2):864-868. doi: 10.1080/09546634.2020.1782822. Epub 2020 Jun 26.
8
Should patients stop their biologic treatment during the COVID-19 pandemic.在新冠疫情期间，患者是否应该停止生物制剂治疗？
J Dermatolog Treat. 2020 Jun;31(4):317-318. doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.
9
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?在新冠疫情期间，化脓性汗腺炎的生物治疗与银屑病的生物治疗有何不同？
J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.
10
Patient's perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice.患者视角：146例在实际临床实践中接受生物药物和小分子药物治疗的银屑病患者在新冠疫情期间的心理负担
J Dermatolog Treat. 2022 Mar;33(2):1185-1187. doi: 10.1080/09546634.2020.1790485. Epub 2020 Jul 9.
引用本文的文献
1
A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.一项关于探究2019冠状病毒病（COVID-19）与银屑病相互影响的系统评价和荟萃分析：聚焦银屑病患者的COVID-19病程及在此背景下对生物制剂的看法。
Immun Inflamm Dis. 2023 Nov;11(11):e1063. doi: 10.1002/iid3.1063.
2
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A Review.COVID-19大流行期间皮肤科的治疗依从性：一项综述
Cureus. 2023 Jan 24;15(1):e34141. doi: 10.7759/cureus.34141. eCollection 2023 Jan.
本文引用的文献
1
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic.皮肤科医生在新冠疫情期间对银屑病治疗的态度。
Drugs Context. 2021 Jun 9;10. doi: 10.7573/dic.2021-4-4. eCollection 2021.
2
Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic.新冠疫情期间银屑病患者生物制剂起始治疗率下降。
Br J Dermatol. 2021 Sep;185(3):671-673. doi: 10.1111/bjd.20406. Epub 2021 Jun 14.
3
How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study.COVID-19 如何影响银屑病的治疗实践、处方模式以及银屑病患者的医疗服务提供？一项横断面调查研究。
J Cosmet Dermatol. 2021 Jun;20(6):1573-1579. doi: 10.1111/jocd.14104. Epub 2021 Apr 3.
4
Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.COVID-19 大流行期间生物治疗的银屑病患者监测：单中心经验。
Dermatol Ther. 2021 Jan;34(1):e14700. doi: 10.1111/dth.14700. Epub 2020 Dec 28.
5
Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey.多中心研究评估 COVID-19 爆发对土耳其皮肤科门诊患者的影响。
Dermatol Ther. 2020 Nov;33(6):e14485. doi: 10.1111/dth.14485. Epub 2020 Nov 9.
Zotero 插件